These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2296571)

  • 21. Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning.
    Parrott AC
    Aviat Space Environ Med; 1989 Jan; 60(1):1-9. PubMed ID: 2647072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of motion sickness remedies in severe sea conditions.
    Gahlinger PM
    Wilderness Environ Med; 2000; 11(2):136-7. PubMed ID: 10921365
    [No Abstract]   [Full Text] [Related]  

  • 23. Transdermal scopolamine precipitating narrow-angle glaucoma.
    Fraunfelder FT
    N Engl J Med; 1982 Oct; 307(17):1079. PubMed ID: 7121520
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety of double-dose transdermal scopolamine.
    Bar R; Gil A; Tal D
    Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transderm Scop patches for prevention of motion sickness.
    Johnson P; Hansen D; Matarazzo D; Petterson L; Swisher C; Trappolini A
    N Engl J Med; 1984 Aug; 311(7):468-9. PubMed ID: 6749195
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.
    Gil A; Nachum Z; Tal D; Shupak A
    Clin Neuropharmacol; 2012; 35(1):37-9. PubMed ID: 22139622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal scopolamine for motion sickness.
    Med Lett Drugs Ther; 1981 Oct; 23(21):89-90. PubMed ID: 7027000
    [No Abstract]   [Full Text] [Related]  

  • 28. More on Transderm Scop patches.
    N Engl J Med; 1984 Nov; 311(21):1377-8. PubMed ID: 6493292
    [No Abstract]   [Full Text] [Related]  

  • 29. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal scopolamine in motion sickness.
    Cronin CM; Sallan SE; Wolfe L
    Pharmacotherapy; 1982; 2(1):29-31. PubMed ID: 6927209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
    Pingree BJ; Pethybridge RJ
    Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cycloplegia from transdermal scopolamine.
    Chiaramonte JS
    N Engl J Med; 1982 Jan; 306(3):174. PubMed ID: 7054664
    [No Abstract]   [Full Text] [Related]  

  • 33. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors.
    Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D
    Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central anticholinergic syndrome in a pediatric patient following transdermal scopolamine patch placement.
    Holland MS
    Nurse Anesth; 1992 Sep; 3(3):121-4. PubMed ID: 1445954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal scopolamine as a cause of transient psychosis in two elderly patients.
    Mego DM; Omori JM; Hanley JF
    South Med J; 1988 Mar; 81(3):394-5. PubMed ID: 3347867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of transdermal scopolamine upon psychological test performance at sea.
    Parrott AC; Jones R
    Eur J Clin Pharmacol; 1985; 28(4):419-23. PubMed ID: 4029247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal scopolamine use in the control of narcotic-induced nausea.
    Ferris FD; Kerr IG; Sone M; Marcuzzi M
    J Pain Symptom Manage; 1991 Aug; 6(6):389-93. PubMed ID: 1880439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unilateral mydriasis caused by transdermal scopolamine.
    Rubin MM; Sadoff RS; Cozzi GM
    Oral Surg Oral Med Oral Pathol; 1990 Nov; 70(5):569-70. PubMed ID: 2234876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI).
    Seo SW; Suh MK; Chin J; Na DL
    Arch Gerontol Geriatr; 2009; 49(2):204-207. PubMed ID: 18834638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time.
    Howland J; Rohsenow DJ; Minsky S; Snoberg J; Tagerud S; Hunt SK; Almeida A; Greece J; Allensworth-Davies D
    Int J Occup Environ Health; 2008; 14(4):250-6. PubMed ID: 19043911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.